Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998–2018

BACKGROUND: Invasive pneumococcal disease (IPD) is a major cause of pediatric morbidity and mortality. Pneumococcal conjugate vaccines (PCVs) were introduced in the US in 2000 (PCV7) and 2010 (PCV13). This study estimated the annual incidence rates (IRs) and time trends of IPD to quantify the burden...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Tianyan, Song, Yan, Done, Nicolae, Liu, Qing, Sarpong, Eric M., Lemus-Wirtz, Esteban, Signorovitch, James, Mohanty, Salini, Weiss, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442936/
https://www.ncbi.nlm.nih.gov/pubmed/36064378
http://dx.doi.org/10.1186/s12889-022-14051-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442936/
https://www.ncbi.nlm.nih.gov/pubmed/36064378
http://dx.doi.org/10.1186/s12889-022-14051-6

Ejemplares similares